CLINICAL_TRIALS
trial_result
· 2015-10-29
Clinical Trial Update: A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia [Phase 2]
Summary
Phase 2 study evaluating azacitidine (Vidaza) in patients with chronic myelomonocytic leukemia has completed, and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Utah | Conditions: Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-10-29